At the end of 2008 the EBMT Nursing Board decided to create a Paediatric Committee, offering an answer to European nurses requests for specifi c knowledge and focus points on infants and adolescents. This committee held their fi rst meeting during the 25th Meeting of the EBMT Nurses Group in Goteborg (March 2009) where initial discussions took place regarding the working of the group and possible projects to take forward. The second meeting was carried out during the 2nd Training Course on Blood and Marrow Transplantation in Genoa (June 2009). The team consists of three members, all from different countries; Merja Stenvall (Finland), Marco Deiana (Italy) and Eugenia Trigoso (Spain). Our fi rst task was to send a survey questionnaire to hospitals across Europe, in order to identify: paediatric centres or centres for adults with paediatric patients, the training of paediatric nurses in different countries, and last but not least, what are nurse's expectations from the EBMT NG Paediatric Subcommittee. The results of this survey will guide the EBMT NG Paediatric Committee in its decisions of education and projects in the future. During a face to face meeting in September 2009 we fi nished the fi nal draft of our "terms of references" and planned our next steps to analyse the questionnaires and present the results in Vienna. The Paediatric Committee is also taking part in the development of "Interactive educational material for pediatric bone marrow transplantation nurses" in cooperation with other Working Parties.
Nurses Session 1: Paediatric issues 1 N1055 Survey on paediatric HSCT nurses in Europe M. Deiana, M. Stenvall, E. Trigoso on behalf of the EBMT NG Paediatric committee
The EBMT Nursing Board decided to create a Paediatric Subcommittee. This committee held their fi rst meeting during the 25th Meeting of the EBMT Nurses Group in Goteborg where the initial discussions took place regarding the working of the working of the group and possible projects to take forward. The committees' fi rst task has been to send a survey questionnaire to hospitals across Europe, in order to identify paediatric centres or centres for adults with paediatric patients, training for paediatric nurses and nurses' expectations for the EBMT NG Paediatric Subcommittee. Questionnaires were sent to all EBMT registered centres and the analysis is still on the way. We got back 61 questionnaires from 18 countries and 46 hospitals. Only paediatric patients have 28 centres and 12 centres have mixed patients. Twelve centres have JACIE accreditation, 8 are in some phase of the process and 26 have no accreditation. There were several aspects asked. Age of the patients varies from few months to 18 (25). For allogeneic transplant 33 centres use BM, pbsc and cord as the source of the graft. We also asked the number of nurses by shift and number of beds. Nurses' education varies a lot in different European countries. Some countries have specialisation studies for paediatric nursing and some for oncology / hsct nursing. Nurses do have also annual planned training on different topics concerning HSCT. Some nurses have obligatory training and are also supported to seek for further education. When asked about attendance to international meetings EBMT congress was mentioned 26 times also EBMT Nordic Forum, SIOP, ASH, NOBOS, ESID, INGID, ECCO, EONS and ONS were mentioned. When asked what nurses are expecting of the new committee a large number of suggestions were proposed: website that nurses could use to share ideas/issues, meetings and training courses on different topics. There is also need to standardize practices and procedures. Special issues mentioned were adolescent care, palliative care, cooperation with multicultural families, nutrition and sexuality. At the moment we are having discussions how to full fi ll the expectations. We are planning to have a Contact nurse in every paediatric centre to make it easier to communicate.
N1056 One profession -two worlds of employment -one aim I. Gruber St. Anna Children Hospital (Vienna, AT)
My tasks and experiences as a paediatric nurse caring for a rehabilitation camp for children and teenagers after cancer treatment. Since 25 years I am qualifi ed as paediatric nurse at the St. Anna Children Hospital stem cell transplantation-unit. An exciting but challenging profession. Everyone who works in it, has announced that after a hospital stay-of the daily life of patients is still far away from commonplace. Allthough we often expect that children return quickly to their normal life after successful treatment, the way back is quite stony for the whole familie. They are fare beyond their expectations and the burden of late effects is still present. The "national organization for children's cancer care" aims to assist patients and their families with reintegration. The "rehabilitation camps" play a centrale role and offer tailord programs for the needs of various age groups. The professional team of educators, psychologists, psychotherapist, and a paediatric nurse offer the children a platform of a well-prepared 10-day-game history to exchange experiences and disease specifi c. For this purpose I was trained as a leisure educator for one year to accompany these camps. My duties at the camp are medical treatment, supervizing and supporting the children with nursing measures. (e.c. subcutane application of growth hormones) Minor "accidents" are fi rst aided from me, and I indicate a doctor's visit. The work outside the hospital is much joy and motivation for me. It's nice to see how they make their own progressions during the post-care-camp after a long and serious illness by making experiences to handle a change in living conditions. We trie S332 to show them posibilities of ways back from the daily routine to self-determination. One of the majorgoals is not only but also teamwork within the peer group handling the daily routine. I want to point of the importance and effectiveness of aftercare camps, and aware of all concerned groups of professionals. For me, working in a rehabilitation camp is a very satisfactory enrichment and it infl uenced my personal attention in the stationary everyday anew. Over the past forty years clinical bone marrow transplantation has evolved to become a major curative treatment modality for several hematological disorders both acquired and genetic. Transplant centers worldwide differ in styles of function to provide the best possible patient care given the size of the program and available resources. Oman with a population of two million, initiated a small BMT program in 1995 as part of an initiative of the hematology department of the Sultan Qaboos University hospital. The program is highlighted by a combined adult and pediatric transplant unit. Between 1995 and 2009 a total of 159 patients underwent hematopoietic stem cell transplantation in this center. The median age was 11 yrs and ranged from 64 days to 55 years. The majority (96%) were allogeneic transplants while the rest (4%) were autologous. Hereditary disorders (46%), hematological malignancy (47%) and aplastic anemia (7%) comprised the transplant indications. Of note six patients were under the age of one year with a median weight of 5.6 kg (3.5 kg to 7.4 kgs). At present a total of twenty-four nurses run the transplant unit providing 1:1 nursing care in all shifts. While a few nurses were recruited with some form of transplant nursing experience, the majority received in-service training in this center. In addition, to enhance nursing care for the infant transplant patients, we initiated an ongoing training program where transplant nurses undergo a rotation in the general neonatal unit of this hospital. In order to facilitate the administration of drugs by the nurses and to minimize medication errors, the clinical pharmacist provides a pre-calculated drug sheet for all children below the age of one year where the doses and dilutions of all commonly used drugs for the particular patient are specifi ed. The BMT program in Oman is an example of a very successful combined adult and pediatric initiative. For a country this size, such a program provides effi cient utilization of resources, avoids unnecessary duplication of manpower and offers the transplant nurse diversity in the range of patient care responsibilities.
N1057
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Employing an integrated approach in the delivery of information to young people undergoing a bone marrow transplant -Tell it like it is J. Vevers (1) There has been a growth of dedicated cancer services for young people within the United Kingdom over the last 20 yrs and the needs of young people are increasingly attracting more attention. As part of a growing transplant service offered within an aged appropriate setting at UCLH (13-19 yrs), it was felt that information should be tailored to their age group and support this expanding service. Recognising how young people access information in today's media world led to the development of an innovative DVD featuring the young people themselves telling it like it is, this will form part of the presentation. Objective:
To explore whether peer to peer information giving was of interest to young patients. Following the above, develop a new innovative, integrated, information tool to support the written and verbal information given to young people in pre-transplant clinic. Method: Using a proforma, all patients who had received a transplant through the support of the dedicated adolescent transplant consultant were invited to take part in a taped interview (n = 20), median time from transplant 21 mths. Participating staff were also asked to answer the proforma, in order to aid comparison. Qualitative analysis of the data allowed for coding and emerging themes. Results: The interviewees were frank and insightful about the impact and effect of going through a transplant both on themselves and on their family. The transcripts were analysed using qualitative themed analysis. Emerging themes such as 'containment' were identifi ed and later helped to edit and develop a DVD which featured young patients informing new young patients about their impending treatment. Conclusion: Young people were willing to put their own experiences forward in order to support and inform others who are about to undergo a transplant. The development of this tool challenged the way health professional's present information, it was seen as a positive acquisition for the service. Using the DVD enabled young people to access important information in a more user friendly format, which could be repeatedly viewed or seen as a podcast. It gave them the ability to view it by themselves, with their parents or with their peers. The tool is not a replacement for other forms of information giving. But it is a useful additional method. Objective: Hematopoietic stem cell transplantation (HSCT) is associated with numerous physical and psychological longterm adverse effects, e.g. increased fatigue and reduced levels of daily physical activity. Several benefi cial effects of physical exercise interventions are reported. Before developing a physical exercise intervention, it is important to know which factors relate to quantifi ed daily activity behaviour. The aim of this study was to determine factors that predict modifi cation in quantifi ed ambulatory walking activity of HSCT recipients. Methods: Cross-sectional data were collected and analysed from a subset of 100 (64 men/36 woman) adult ambulatory patients after completion of HSCT and after discharge from hospital. We used a step activity monitor to measure the dependent variable average ambulatory steps during 7 days. The independent variables were the result of a six-minute walking test, knee extension strength, days after transplantation, hemoglobin value, self-reported physical activity, self-reported fatigue, type of disease, stem-cell donor type, age and gender. Associations were calculated with stepwise linear regression analyses. Results: The average age was 47.2 years (± 13) and the average daily steps were 5155 (± 1930). Sixty-fi ve patients • • S333 received autologous and 35 patients allogeneic HSCT. There was only a signifi cant association between average ambulatory steps/day and fatigue (p = 0.03). Subgroup-analyses yielded signifi cant associations between fatigue and older male patients (p = 0.02), in contrast to younger patients. There were also signifi cant associations between autologous stemcell donor type and older female patients (p = 0.02), between autologous stem-cell donor type and disease type (multiple myeloma, p = 0.03), and between fatigue and autologous stemcell donor type (p = 0.007). Conclusion: Self-reported fatigue could be identifi ed as a predictor for daily ambulatory walking activity. The mechanism and relationship between quantifi ed daily activity and severe fatigue needs to be investigated further, and longitudinal studies of the effects of physical exercise interventions and other factors (e.g. psychological) are needed.
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Nurse-led rehabilitation consultations in an outpatient clinic
Background: Patients treated with allogeneic stem cell transplantation are challenged physically, psychologically, socially, economically and spiritually. They are at risk of getting a large variety of early and late complications compromising their ability to work, enjoy family and social life, affecting physical and mental well being for a long period post transplant. I 2005 the Danish government published a new public health legislation and the second National Cancer Plan, both emphasizing prevention of illness and disease and promotion. Both the health legislation and the cancer plan emphasize rehabilitation as an important part of treatment and recommend that, it is initiated as early as possible, preferable already in the hospital setting. Method: Literature search and participating in educational sessions and courses in rehabilitation. We have looked for studies investigating up to fi ve years post transplant. We have searched for studies on physical as well as psychological, social and spiritual issues, carried out in transplant settings similar to our own clinic, based on patients and conditioning regimens. The studies cover issues like quality of life, recovery and long-term functioning and changes in neuro-psychological and sexual functioning. Result: We developed a concept for nurse-led rehabilitation consultations. The consultation is carried out as conversations with the patient, and will be offered at 3, 6 and 12 months post transplant, in connection with an outpatient visit. The primary nurse is responsible for the planning and coordination. We have made a booklet for patients: Rehabilitation -getting the best life possible during and post treatment. A standard letter confi rms the appointment with the patient, and the patient is requested to prepare for the conversation by ending some unfi nished sentences also in the letter. We made a guide for the nurses to use both for preparation prior to a conversation as well as during if the patient has not prepared a specifi c issue to discuss. Conclusion: We have carried out ten conversations by now. The patients have been satisfi ed with the opportunity to discuss issues that troubles them in their daily life, and found the conversations supportive. Mainly female patients have been interested in this type of consultation, indicating that the concept needs evaluation and adjustments. HSC graft infusion is a great moment for the patients, always very emotional, which could be an hopeful as well as a stressful step procedure toward the cure. In order to alleviate the anxiety induced by the graft infusion we proposed to the recipients seances of sophrology all along the early period of their hospitalization for HSCT. Methods: It is a comparative non randomized prospective study based on patients undergoing HSCT and volunteering for the sophrology support proposed as followed:one 30 minutes seance at day-1, day 0 during graft infusion, and then once a week for 2 weeks. The control group included patients undergoing HSCT during the same period but who did not accept to be included in the sophrology program. The study comprised 3 parts: physiological impact translated by the vital signs parameters such as blood arterial pression (AP), pulse rate and arterial saturation in O 2 (SaO 2 ) registered during the infusion procedure psychological impact through a patient questionnaire nurses in charge experience through a questionnaire given at day 0 at the end of the infusion procedure. Results: Sophrology was proposed to all consecutive patients undergoing HSCT, either autologous or allogenic, between january and august 2010. Twenty three patients were included comprising 11 patients with sophrology [group S] and 12 patients without sophrology [group C]. Physiological parameters during graft infusion: -reduction of the arterial blood pression for the study group comparatively to the control group: 19.2% for systolic pression and 13.4% for diastolic pression -1.4% increase of the SaO 2 in the group S comparatively to the group C. Questionnaires: -37% of the patients of the sophrology group experienced a benefi t in term of peacefulness and anxiety decrease. -all the nurses in charge of the graft infusion experienced a greater serenity during the care due to the patient calmness and to the presence of the soprologist. Both questionnaires will be detailed in the presentation. In conclusion, sophrology seems to provide advantages for the volunteer patients undergoing HSCT and needs to be investigated in other phases of the disease.
N1061
N1062 GITMO survey on sexual issues in patients undergoing HSCT: results of a questionnaire sent to nurses
Sexuality is an important part of a relationship, concerning the individual physical and mental health, and it is essential in the integration with partner, family and social group. The "Italian Group for Bone Marrow transplantation" (GITMO) considered useful a survey between "Haemopoietic stem cell transplantation (HSCT) centres" in order to show the point of view about the information levels related to issues in the sexual sphere of the patients undergoing HSCT; the information methods used by centres and the possible existence of specifi c training courses for nurses. For this purpose a 15-questions survey was prepared and sent to "GITMO adult centres" (73 in all). The collected data were entered into a database and analyzed.
1.
3.
30 centres participated to the survey (42% of the total of GITMO centres). One paediatric centre sent its data, because they treat patients of age too. The nurses involved were 542. The 86% answered the survey for a total of 467 nurses; 400 of these were validated. The population involved in the study has been working in HSCT unit for a period between at least 5 months to at most 30 years and 4% works with patients undergoing allogeneic transplantation, 11% with autologous patients, 85% with both autologous and allogeneic. Most nurses believe that diseases and transplantation have important effects on patients sexual life, so the psychological support is not only useful but necessary, and must be provided in a systematic way and not only on demand. The data analysis conclude that most of the centres provide the psychological support and information on the issues related to sexuality to the patients during the pre-transplantation phase and at the discharge. Doctor is the main fi gure involved and in most cases provides the standard information. The negative data is that a large part of the nurses do not consider suffi cient and comprehensive the information; there is a lack of time to ask questions, so that patients have to ask to nurses for more information and nurses also consider unsuitable the setting. Negative is the fact that there are few centres that offer a facility for training staff on issues relating to sexuality in patients undergoing HSCT. The survey also shows how nurses who work in the same ward often give different answers to questions about structures and procedures. This must make us refl ect about possible interpretations of contradictory data and how to read them. Background: Many protocols for the prevention of oral mucositis recommend pre-clinical dental evaluation for every patient before the stem cell transplant. However, precise information on what is involved in the dental evaluation is sparse. In our hospital, we advise every patients to visit their own dentist for evaluation so as to allow any necessary treatment to be undertaken before the transplant. Unfortunately we do not know whether patients follow this advice nor what sort of dental care was given. Occasionally the poor oral health of some patients calls into question whether it is even responsible to undertake the transplant. Methods: The objective of this study was to make an inventory of the dental care received by recipients of a stem cell transplant during 2008. A survey was conducted among 40 recipients by telephoning each one and by writing to the professionals i.e. their dentist or dental hygienist. Results: Only one of forty recipients asked did not visit the dentist. All but 1 patient (97%) needed dental treatment which involved removing plaque and calculus in 70% of cases. In total 93% of the dental professionals responded to the survey and their answers confi rmed the prevailing opinion that a comprehensive oral evaluation should take place before cancer treatment starts to allow adequate time for recovery from any intervention that might be needed. The list of problems identifi ed included: identifying alveolitis, gingivitis, periodontitis, peri-coronitis, pulpitis and in determining the current oral health status. Dental professionals also recommended using appropriate techniques such as x-ray to detect possible sources of infections and confi rm the periodontal status. Preventative measures including providing dental hygiene instructions and fl uoride treatment were also recommended. Conclusion: The oral cavity should be evaluated to reduce the risk and severity of oral complications and to identify and treat existing infections during cancer therapy. Subject: Patients with a haematological malignancy have a signifi cantly increased risk of developing a life-threatening infection. Therefore effective infection prevention is of crucial importance and Low Bacterial Diet (LBD) has historically been regarded as an integral aspect of this strategy. The objective of the LBD is the protection of patients from infections by restricting the intake of food with potentially pathogenic micro-organisms. There is no consensus regarding the practice of using a LBD. The extent to which a LBD plays a role in the prevention of infection in patients with a weakened immune system remains questionable due to the lack of rigorous clinical data. However, LBD continues to be implemented in the care of neutropenic patients despite the lack of scientifi c evidence, is this acceptable in the current age of evidence based care? Method: Cochrane reviews explore the evidence for and against the effectiveness and appropriateness of treatments (medications, surgery, education, etc) in specifi c circumstances. A Cochrane systematic literature review was undertaken to assess the usefulness of LBD in neutropenic patients. The "search" was primarily aimed at randomised clinical studies (RCT) to compare LBD with other/normal diet. Objective was to determine whether LBD protection in a period of neutropenia against gram positive and Gram negative infections, fungus infections and the related mortality. Results: From 54 possible articles, a total of 4 were eligible for analysis. There was no statistical difference found in the prevention of infections and mortality. Further results demonstrated that there is very little justifi cation for the use of LBD. Conclusion: This lack of scientifi c evidence questions the hypothesis that LBD should be routinely adopted as part of supportive care strategies and asks the question should this practice be abolished? However, it is important to note that despite the lack of evidence to support LBD, neutropenic patients remain a high risk group. Infection prevention strategies concerning diet provision for this patient group need further exploration in a systematic way. Recommendation: An international guideline seems a logical continuation. Food education is an important issue and hygienic remains central for the prevention of infections in these patients, but must be implemented with a broader perspective, rather than a complete ban on diverse food products.
Nurses Session 3: Management issues
N1067
N1068
Autologous peripheral stem cell transplantation: risk assessment using a co-morbidity score index
Comorbidity is any distinct additional clinical entity existing or possible during the clinical course of patients with haematological malignancies. With the development of non myeloablative haematopoietic cell transplantation (HCT) regimens and improvements in the supportive care after myeloablative HCT regimens, more patients with comorbities are being offered allogeneic HCT. The specifi c index (1) named Sorror Index (SI) provides valid and reliable scoring of pretransplant comorbidities that predict non relapse mortality and survival. The SI is currently used for allogeneic HCT by many Bone Marrow Transplantation Units. Contrary, no data exist about their application in patients underwent to autologous bone marrow transplant. In our Institution we retrospectively assessed a setting of patients with haematological diseases transplanted with autologous stem cells from January 2008 and October 2009 to verify if the SI have an impact on the outcome and the survival of these patients. We studied 106 consecutive patients with median age of 51 years (r. 14-69). The main diseases transplanted were lymphoproliferative diseases (72.7%) and acute leukaemia (18%). The conditioning regimen used depended on type of transplanted disease, including high dose of Melphalan for Multiple Myeloma, BEAM or FEAM protocol for Hodgkin and non Hodgkin lymphoma and BuCY2 or BuFlu for acute leukemia. As source of stem cells we used PBSC in 99.1%. The median number of CD34 + cells infused was 5.5 x 10E6 / kg (r. 2.3-8.9). All patients engrafted. After a median follow-up of 285 dd the 91.5% of patients is alive and the 4.7% relapsed. The only cause of dead was the reappearance of disease. Considering SI, the 31.1% of patients had a score > 1 (1 = 23.6%, 2 = 4.7%, 3 = 2.8%). The main comorbidities were the obesity, diabetes mellitus, hepatic and liver dysfunction. All patients but 4 (3.8%) with SI = 0 were alive. Of 9 patients that relapsed, 4 had SI > 1, while the remaining had SI 0. Among the patients dead, only 4 had SI > 1. These preliminary data showed that the SI is probably predictive on survival of patients underwent to autologous transplant with SI = 0. Considering the low number of patients with SI > 1, it's necessary a larger number of cases to better determine its applicability in the context of the autologous transplant. In conclusion, in our Institution we are considering if SI is an important factor in terms of other variables such as complications and responses to transplantation. Background: JACIE standards (B3.7.1, B3.7.5, B3.7.6) recommend adequate numbers of experienced nurses in the care of stem cell transplant (SCT) patients. This is not fully defi ned and there is no clear guide as to what ratio is ideal. Despite data suggesting that hospitals with low nursing levels have higher rates of poor patient outcomes, demonstrating this within the SCT environment is essential in justifying our highly skilled workforce in the current economic climate. It is hypothesised that the Modifi ed Early Warning Score (MEWS) could be a valuable measure to determine the acuity of SCT patients and also fl uctuating nurse to patient staffi ng needs. The MEWS is a physiological scoring system that identifi es patients at risk of deterioration who require increased levels of care (e.g. 0 = stable; 3 = risk of rapid deterioration/referral to outreach; 20 = critically unstable). Project: A retrospective analysis of 21 SCT patients admitted to Level 2-3 care during January-September 2009 was done. The MEWS at fi rst point of patient deterioration; referral to outreach and transfer to the high dependency unit (HDU) was reviewed. Results: 15 patients were admitted for respiratory failure; 4 for sepsis; 1 for nephritic syndrome and in 1 case the cause was not documented. The MEWS range at point of deterioration was: 2 -6; at referral to Outreach: 2 -8 and at transfer to HDU: 2 -8. The median time that patients were nursed on the ward before transfer to HDU was 3 days. Nursing interventions required at ward level included: 15 minute observations, hourly urine measurements, high levels of oxygenation and the use of birding for respiratory support. Discussion: Our results suggest that the MEWS score may not truly map the deteriorating condition of SCT patients. MEWS does not measure respiratory and renal function fully. Respiratory deterioration was the key cause of admission to higher levels of care and therefore it is important that this is refl ected in any acuity scoring system. The MEWS remained fairly constant from the time of deterioration to transfer; despite patients' increasing dependency. Therefore MEWS is a trigger tool for nurses to escalate care, but it does not accurately indicate level of acuity. Recommendations: An adapted acuity scoring system for SCT patients is needed that takes into account all the physiological parameters that necessitate escalation of care and guide what ratio of experienced nurses in the care of SCT patients are needed.
Nurses Session 4: Information and technology
N1073
Online patient education on a personalized laptop for every patient: can it be tailored?
J.W. Hoekstra, A.P.M. Mank AMC Amsterdam (Amsterdam, NL)
Background: Patient education is an important aspect of goodquality care. Most people want to have all possible information about diagnosis, treatment, treatment outcomes, side effects and quality of life, especially all the information about Stem Cell Transplantation and the care around it. The patients want to have information before the hospital admission as well as during and after the admission. The given information from the doctor, transplant coordinator, ward nurse etc. needs to be supported by paperwork, audiovisual and digital information. Many patients turn to the internet for information, for instance the hospital-website but also the World Wide Web for suggestions regarding their treatment. We see more and more the need from the patients on the ward to search for digitalized information. On the other hand it is diffi cult to keep the written information up to date, at this moment. Objective: As we want to serve the patient in his or her personalised need for information, there will be a project to combine two issues. The goal will be to update and digitalize our patient information and put it on a laptop patients can use during their admission period, and their personal use for instance the internet and email. The whole area of diagnosis, treatment, SCT, side-effects, recovery and going home should be in the program. For example they can look for their treatment protocol, own chemotherapy schedule, blood results, medication etc. and print it. After discharge all the information can be taken home on a memory stick. We will ask them to fi ll in a patient satisfaction survey. Methods: The members of the project (patient information service, ICT and ward representative) will discuss the condition about which information which format, and for instance how to clean the computer after discharging the patient. Big job will be what kind of information is already digital and what do we miss? It will start as a pilot project with evaluations from nurses and patients. Results: We want to improve the way the doctors and nurses are giving information. By this project we expect a format to make it possible to enter that new way of giving digital information. Hopefully the patient will be well informed about his treatment, admission and care around his SCT.
N1074 Breaking new ground -The EBMT (UK) NAP group patient, family and friends forum M. Kenyon, L. Ritchie, T. Rintala, A. Pagliuca on behalf of the EBMT (UK) NAP group
Introduction: There is considerable evidence that cancer patients can benefi t from participation in patient forums. Fellow patients may provide positive role models, shared understanding and information not always available from other sources. Forum participants report feeling less alone, better understood, and more hopeful following their group experience. The EBMT (UK) NAP group has recently established a patient, family and friends (PFF) forum with funding from the Elimination of Leukaemia Fund (ELF). Running alongside the EBMT (UK) NAP meetings, the PFF fora hope to provide a source of high quality information and support. The inaugural meeting was divided into four sessions, three delivered by health professionals (physiotherapist, dietician, counsellor) and one by a patient (art therapist). Methods: We handed out anonymised evaluation forms to speakers and delegates to generate feedback. Divided into 3 sections (I overall impressions, II speaker appraisal, III general feedback), forms were completed and returned. Items in sections I and II were scored from 1 to 10 (1 = poor, 10 = good). Results: There were 16/16 returns (7 patients, 5 family/ friends, 4 speakers). Not all items were completed by all respondents. Mean values of selected items are presented in Tables 1 and 2 . Numerous comments were made in the general feedback section. Patients requested more art therapy and talking time. Family requested more talking time, alternative therapies/ coping mechanisms and more 'upbuilding talks'. All respondents indicated that they would wish to attend future meetings. Conclusions: The meeting received positive feedback from all three groups. Organising a PFF is a viable exercise, appealing to both delegates and speakers. Delegates appreciated the range of topics available and specifi cally requested more time for open discussion and talking to each other. The family group rated the art therapy session lowest as was also refl ected in their general feedback. This session, a presentation of a patient experience illustrated through art, including a frank and personal account of their journey which may been uncomfortable for some delegates. This highlights that different needs and expectations may exist between patients and families which future meetings will seek to address. Our experience of this forum demonstrates not only that a need exists, but that delegates found this forum relevant and interesting, pledging unconditional, unanimous support for future meetings.
N1075 Using the Internet as a networking tool; bringing nurses together J.C. Morrow, D. Collins BMT Network NSW (Sydney, AU)
The Blood and Marrow Transplant (BMT) Network is a clinician-led network which aims to assist all NSW BMT units in improving patient outcomes, by using a collaborative and communicative method towards enhancing service delivery. New South Wales is the most populated state in Australia, with 7.0 million persons in 802,000 km². There are 15 BMT units in NSW with all being located in metropolitan Sydney, where the majority of the population reside, 4.5 million. The regional and rural hospitals in NSW support BMT patients with pre and post transplant care. The internet is widely used by people as a source of communication and information. This resource can be harnessed to provide nurses with an ability to communicate with each other and exchange information. The BMT Network developed a dynamic website to benefi t BMT clinicians. The website is used as an information resource and education and communication tool. Incorporated into the website were three discussion forums for use by scientists, doctors, and nurses. Nurses who are registered network members were given access to the forums where they could pose questions regarding best practice issues in BMT. The website has the ability for the questions to be answered by other members of the nurse's discussion forum. The website programme will send an email that alerts members of the forum about the each discussion question, they then go on line and offer an answer. The success of the nurse's forum using the website as a medium for discussion is evidenced by the number of questions posed, the number of views by members and the number of replies to the questions. In the one month period from 20/10/09 to 23/11/09, eight questions were posed with 755 views and 38 replies to those questions. The BMT Network website now has nursing members from BMT Units globally. The ability for nurses to communicate across the world regarding clinical issues in BMT highlights that theses issues are not necessarily unique to NSW. In order to effectively evaluate this method of communication for nurses, an evaluation form has been distributed to all nursing forum members seeking their feedback and comments. This evaluation process will provide the BMT Network with information on ways maintain and improve this service as an effective communication and information sharing tool.
N1076
The development of a guidance document; guidance for the preparation, administration and safety considerations of nebulized ribavarin using the Aiolos nebulizer
L. Parrack on behalf of The Ribavarin Working Group
Ribavirin is a broad-spectrum antiviral agent, which inhibits a wide range of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) viruses by disrupting viral protein synthesis. The current licensed Virazole ® (ribavirin for inhalation) is for RSV, but is widely used in other viral infections. There have been diffi culties following the discontinuation of the small particle aerosol generator (SPAG) and the transition to the AIOLOS nebuliser. There have been many issues vocalised regarding concerns of nursing staff over the delivery of ribavirin by nebulisation. These encompass both the technical aspects of the equipment and the safety considerations. A multidisciplinary team (MDT), of experienced ribavirin users which included healthcare professionals from hospitals across the United Kingdom, came together to evaluate and discuss all the relevant issues and by consensus develop a guidance document. The results of which consolidate best practice, and go someway to decrease the concerns of staff by addressing the myths around the usage of ribavirin. The purpose of this document is to act as a reference material for healthcare professionals who are being trained in the preparation and administration of the drug ribavirin by nebulisation. It is also intended as a reference for those who are deemed to have been competently trained. It has been widely recognised that there has been a demand for a document such as this to provide information on the use and environmental exposure to nebulised ribavirin. The ribavarin working group are proud that this guidance document and DVD are available from the end of November 2009. 
Nurses
have experienced -why also do not look once behind the hospital walls in Reykjavik and see how the colleagues work there, which terms of employment they have and how their education is built up. Because Iceland is a rather small country with a very low population density, there is there even one really big hospital -in the metropolitan area Reykjavik where just 200,000 of the 320,000 Icelanders live. In view of these small population fi gures arises per year even a low number of about 20 patients who have an autolog transplantation and 5-8 patients who have an allogenic transplantation. The fact that is not transplanted allogenic in Iceland and that patients who should get it must travel to Stockholm, was already known to me. Thus the question has interested me how the Icelandic patients experience a therapy which is very loading far from home. In addition the colleagues have carried out the investigations whose results they have introduced by means of a talk and two posters with the last EBMT meeting in Gothenburg. Moreover, I had to get to know on site the opportunity an affected patient and her husband. "Family Care" is called a nursing model which was developed in Calgary, Canada and after which on the hematological ward is worked in Reykjavik. Now my aim is to occupy me with this model in future more thoroughly and to examine whether it can be integrated into our everyday work. Finally I would still like to mention that the activity fi eld, as well as the isolation measures not serious different as at our hospital. It was an interesting experience to be allowed to co-operate on the ward and my thanks are valid for the colleagues in Iceland.
N1084
Meeting the needs of children during hospitalization of a close family member C. Helgesen, A.M. Småvik, I.B. Petterson Oslo University Hospital -Rikshospitalet (Oslo, NO)
Introduction: When parents are diagnosed with cancer, their children are affected and in the need of particular attention and support. Evidence provided by several reports indicates that there is a lack of standardization in how the Norwegian health care system encounters this challenge. In June 2009 the Norwegian government approved a law to strengthen children's rights as next of kin. As of today the children have limited legal rights of support or consideration of such, by law. Objects: To standardize helpful information, give support and care for children as next of kin to a haematological cancer patient. Methods: Based on nurses` clinical knowledge and experience, a brochure was prepared to inform patients about children's visit to the department prior to hospitalization. The nurses were educated through a standardized competence program in 2006. A children's support group was established in 2008, to fi nd and accomplish recommended interventions for children visiting the department. The support group was comprised of nurses with a special interest for the subject. Databases used were Medline, Cinahl and Cochrane. Keywords: children of parents with cancer, children as next of kin, leukemia patient with children, combined in different ways. Results: Based on the increased recognition of children in our department, the environmental attitude has changed toward children's individual needs. They are included in the documentation system, the information brochure is handed out and they have their own play area. A standardized nursing care plan is in process to use as a tool for mapping and evaluation of nursing interventions. The support group is educating nurses, and relevant literature is available for nurses and patients at the department. Conclusion: Increased knowledge of children's health and coping system has resulted in awareness surrounding the issue dealing with a close family member's illness.
The change of Norwegian law of 2009 secures children's legal rights to be involved during hospitalization as a close family member. The law will be introduced January 2010 and imposes all departments in the hospital to have a child contact.
N1085
Patient safety M. Oudshoorn, S. Zulu LUMC (Leiden, NL)
The nursing work environment has a critical impact on patient safety. Lack of nurse empowerment and confusion on the specifi c roles and competencies of nurses can result in safety risk. The clinic has to make it clear what their policy is on patient safety taking into consideration national en international standards. Objective: The nurses are involved in promotion of patient safety on the hematology and bone marrow transplantation ward. Methods: The quality management team formulated and implemented the following goals to promote patient safety by improving and empowering the role nurses play:
Collegial testing: Nursing competencies were examined by colleagues during their work. Competency assessment such as care of central venous and peripherally inserted catheters and care of the patient receiving chemotherapy were tested using a checklist. Compulsory refresher courses: Nurses are obliged to follow the annual resuscitation course and training about restraining procedures for patients who are an endangerment to themselves or their surroundings.
Nurses have increased awareness of critical moments in care proceedings and learn from mistakes and incidents that happen on the ward. This is achieved by error-related problem solving: evaluation of incident reports are discussed with the person involved and the whole team during the quarterly team meeting. Nurses work according to a standard operating procedure involving the prescription, preparation and administering of medication. Nurses are aware of the importance of hygiene during preparation of medication. The critical issues that arise are discussed within the committee for medication safety and necessary actions for improvement are taken. Awareness week: Every year there is one week with a theme highlighting a different aspect of patient safety. Results:
85% of the nurses used their own initiative to be assessed in different competencies this year as opposed to the 80% the year before. 100% attended the compulsory training about restraining procedures. The amount of incident reports has so far increased by 25% due to increased readiness to fi ll in the reports. As a result of highlighting the importance of hygiene and safety during preparation of medication we are introducing the national standards for medication on the ward. Conclusion: Nurses have greater commitment to patient safety. They take responsibility for their own actions and are more likely to communicate about and reveal errors. Background: Early pulmonary complications during the fi rst 30 days after stem cell transplantation (SCT) involve high risks in children undergoing allogeneic SCT. In our nursing project which started four years ago we identifi ed children with very high risk for pulmonary complications (PC) and defi ned them as "high risk patients". The prophylactic use of NIV-CPAP by means of a mask proved to be reasonable in order to prevent intubation and risks of invasive ventilation. As a consequence we established a standard for prophylactic pulmonary support (PPS) for these patients. Objectives: Children of the high risk group are evaluated according to pulmonary case history and clinical diagnostics (pulmonary function tests, NO measurement, bronchopulmonary lavage, thoracic CT). As a result therapeutic treatment is defi ned (antibiotics and inhalations). Nurses and physiotherapists start prophylactic training of NIV-CPAP and breathing therapies. To assess the effects of the methods beginning, incidence and end of pulmonary complications are determined by the following parameters: need of oxygen, venous blood gas pCO2, breathing rate and control x-rays of the thorax. Results: Two years before starting with the prophylactic interventions the number of children with allogeneic SCT was 62. Two of them had pulmonary problems until day + 30 after SCT. In 2006/2007 the number of children with allogeneic SCT was 48. 19 children were in the project group, 3 of them had pulmonary problems until day + 30 after SCT. In 2008/2009 the total rate of allogeneic SCT was 44. 21 were defi nded to be endangered for developing pulmonary complications. 4 of these group needed non-invasive or invasive ventilation.
Conclusion:
Interdisciplinary cooperation should provide for early diagnostics and decision in terms of individual therapy for the patients.
To make children familiar with the interventions in a home care setting implies an optimal preparation for SCT. Prophylactic interventions should include training of NIV-CPAP and medical treatment based on the results of pulmonary diagnostics. During the time of SCT specifi c nursing facilities should be offered and physiotherapeutic treatment should be intensifi ed. Introduction: The use of central venous catheters (CVC) and peripheral catheters is usually necessary for a good clinical practice in patients (Pts) with hematological malignancies.
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Peripheral Inserted Central Catheter (PICC) and Mid-line (ML) have simplifi ed the management of these Pts in which the insertion of CVC was dangerous or not suffi cient to plan therapy. Results: The incidence of systemic catheter related infection was 3.5% in the research group (PICC n = 57). None of the patients developed a local catheter infection. In the control group (CVC n = 51) the incidence of local CVC infection was 3.9% and the incidence of systemic CVC infection was 23.5 %. Conclusion: The introduction of the PICC has resulted in a statistically signifi cant (p < 0.005) reduction of catheter-related infections. Discussion. A possible explanation for the reduction of catheter related infection are differences in insertion and fi xation techniques. The outcome provides a basis for additional study using a bigger sample size and refi ning procedures and evidence based catheter care.
N1094 Audit review of consent to apheresis and traceability of stem cells L.J. O'Regan St Georges NHS Trust (London, UK)
Two specifi c audits were undertaken this year comprising of a cohort of apheresis procedures, and all transplants returned to them, plus stem cells from unrelated donors. Objectives:
To assess the completion of the consent documentation, and assessor competence.
To assess the suitability of the documentation in accordance with the Department of Health, The Human Tissue Authority and Jacie Standards.
Ensuring that the relevant investigations were carried out and documented. Those patients are approved fi t. Assessment of the procedures followed when collecting, storing and returning stem cells. Ensuring a trial is available at each junction of the process. The motivation for the work was to satisfy the requirements of the Human Tissue Authority, and Jacie Version ix standards. Methodology: a retrospective inspection of the patient notes. 21 apheresis procedures were examined. Of the traceability of stem cells; autologous (19%) transplants, all sibling donors and recipients (33%), and matched unrelated, (19%). Each case was entered on a performance sheet, and the results of the categories entered onto pie charts. Main fi ndings: 100% consented, 14% medical non competent. Nursing showed 74% competent. For short stay stem cell storage episode recent documentation was not complete. 50% of the fresh transplants returned were documented. 100% of matched unrelated and autologous transplants were documented. 65% of adverse events not documented. Conclusions: Overall good compliance was observed. Training gaps were identifi ed. The process provided positive impact on staff learning and information given to patients. The internal systems are mostly suffi cient and serve their intended purpose. There was a lack of documentation of fi tness of the patient. It was speculated that the travel history questionnaire should be adopted for all patients in the workup. There were signifi cant gaps in the documentation of the return of fresh, which could be highly signifi cant. Possible discrepancy in where adverse events should be documented led to signifi cant gaps in clinical observation or documentation, not known. The emphasis on professional accountability as opposed to patient understanding may be concerning.
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Working in a JACIE accredited transplant centre,as Apheresis nurses we strive to achieve and manage a nurse-led, evidence based,collaborative service providing exemplary patient and donor care in the collection of peripheral haematopoietic stem cells for autologous and sibling transplant. There is a perhaps a general assumption that in this specialist area there are more similarities than differences with regards to practice both nationally and internationally. What follows is an overview of two apheresis services looking at some core elements of patient management. One is my own unit at the Royal Marsden Hospital, a respected cancer hospital in the UK. The other is a consistently highly ranked FACT accredited academic medical centre, the Cleveland Clinic in Ohio, USA. The following discussion highlights some signifi cant differences and proves that across the pond we are divided by more than just a common language! In the course of this it will be interesting to ascertain if European colleagues recognise and identify with current practice at my institution or that of the US. Noteworthy areas for comparison were nurse education and training; nurse-led vs. medical led service; p eripheral vs. central intravenous access; management of citrate toxicity; follow-up care of donors; average number of apheresis sessions per patient/donor and CD34 target yields. There appears to be a more medicalised and invasive approach to stem cell collection in this particular US unit which will have enormous cost implications as well as increased potential health complications. We perform approximately 85 autologous stem cell transplants (SCT) annually. However there is a signifi cant number of patients for whom this treatment would be appropriate but are unable to mobilise suffi cient CD34 cells with conventional methods i.e, chemotherapy + Granulocyte Colony Stimulating Factor (GCSF) or GCSF alone. The arrival of Plerixafor has provided us with another intervention for these poor mobilisers. Prior to licensing this drug became available to our institution on a compassionate use basis for this category of patients. This is a retrospective analysis of the 22 pts who received Plerixafor to ascertain if our results refl ected those from the previous clinical trials and to look at the nursing and service implications of this therapy. Patients received an am dose of G-CSF on days 1, 2, and 3. On day 3 the patient was admitted and Plerixafor administered by subcutaneous injection at 12 midnight. On day 4 apheresis was commenced by 10 am following a 9 am G-CSF dose. Plerixafor peaks within 6-11 hours hence the timeframes for dosing and initiation of stem cell collection. Results: Of the 22 patients: M(13), F(9). Diagnoses: MM(14), HD(2), NHL(5), GERM CELL(1). Mean age: 60 (26-69). Number of prior therapies: 1(3), 2(3), 3(9), > 3(7). Number of failed mobilisations: 1(16), 2(6). 7 patients had previously had an autologous transplant. 13 pts achieved target CD34 yields, 8 collected enough for one PSCT, (the aim is to collect enough for 2 PSCT for myeloma pts), 1 pt failed to mobilise. Mean CD34 yield: 2-3 10 > 6 (0.11-7.25). 4 pts required 1 Apheresis/Plerixafor treatment; 16 pts required 2, and 2 pts required 3. 15 pts were treated with PSCT. Cells were cryopreserved for future use for the remaining 6 pts. All pts successfully engrafted post transplant and engraftment rates and length of hospital stay were concurrent with conventionally mobilised pts. Conclusion: Stem cell mobilisation and collection can be physically and psychologically demanding for patients and families and failure can exacerbate fears of relapse and survival. There are also nursing and health service implications in terms of time, cost, and resourses: staff, apheresis service, pharmacy input, inpatient beds etc. At the present time Plerixafor requires an inpatient stay. It also demands deviations from our standard operating procedures for stem cell collection. And fi nally there is the question of the future role of Plerixafor now that it is licenced and if funding will be available for this effective but expensive drug. The paediatric stem cell transplantation centre of Frankfurt´s university hospital on the Main annually transplants approx. 50 patients of every age. The effects of this aggressive therapy form are extremely irksome for children and young persons. Particulary the Fatique syndrome (= tiredness, exhaustion) was observed to an increasing degree during the last years. A team of many specialists as there are teachers, musician-therapists, d octors, nurses and others tries to ease the symptoms. The stem cell transplantation centre of Frankfurt has already tried to build up a good atmosphere by erecting a new building and to support the children during the transplantation time. Every room is equipped with television, a DVD-Player and computer. To improve the well-being of the children the shifts are discussed with the children and parents daily and arranged with the other disciplines. Another main focus is the continual caring help. An extra visitation as a team takes place every week in order to discuss the situation of the moment and to look for solutions to help children and families. Phyisical activities are a measure against the Fatique syndrome. Following this attempt the integration of a supportive sport therapy took place at the paediatric transplant station in November 2008. Within the project the children and young persons got regulary sport-therapeutic supervision/attendance on voluntary basis from the day of the transplant up to discharge. For this project students of sport affairs were responsible for leading and arranging. Endurance training on infi ltrated bicycle ergo meters,strength training with small devices as well as coordination exercises were important for the clinical survey. On account of the low case number no signifi cant overall results can be given. Beside the offers for the patients there are offers for the members of the families too to deal with the situation in a better way for example: massage, coffee-time and breakfast for parents, psychological help, mental care; there is also the possibility to stay overnight in the so called parents house. The stem cell transplantation centre of Frankfurt´s university hospital on the Main has got good results in the recent years by following the way described above. The Fatigue syndrome has been avoided as far as possible; it was recognized and treated early. We hope that by subsequent studies we go into further research of this complex illness and to improve the medical treatment of the children in future.
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Clinical pharmacy activities at a paediatric stem cell transplantation unit T. Bauters (1) Background: Clinical pharmacists promote safe, appropiate and effective medication use for patients within healthcare centers. As part of a multidisciplinary team, they are able to closely monitor drug therapy and make recommendations on the selection of the most suitable medication according to the patient's condition, the correct dose and duration of therapy. The benefi ts of clinical pharmacy services are well documented in the literature. However, few reports highlight the role of the clinical pharmacist in pediatrics, especially in the pediatric stem cell transplantation setting (PSCT). Aim: The aim of this project was to establish the importance of a clinical pharmacist in the PSCT ward. Methods/Results: During a 10-week period (non-consecutive days), a total of 142 interventions (based on data of 5 patients) were performed. They included provision of information (14.8%), clinical interventions (78.9%), provision of specifi c products (2.8%) and identifi cation of process faults (3.5%). The clinical interventions (n = 112) were divided as follows: change of therapy (26.8%, e.g. dose-adjustment of antibiotics, identifi cation of interactions, …), increased drug monitoring (55.4%), start of drug therapy (16.1%) and clarifi cation of prescriptions (1.7%). A total of 92% of the clinical interventions were accepted by the medical staff. According to the Anatomical Therapeutic Chemical classifi cation (ATC), most interventions concerned anti-infectives (J, 28.9%), antineoplastic and immunomodulating agents (L, 28.9%), drugs for the alimentary tract and metabolism (A, 23.5%) and drugs for the central nervous sytem (N, 7.3%). The pharmacist was also involved in practical research projects (e.g. development of guidelines for treatment of pain, mucositis, …), information and education on pharmacodynamics, compatibilities, and in administration procedures. Conclusion: A pediatric clinical pharmacist with extra expertise in pediatric hemato-oncology might have a positive impact on prescription behaviour and consequently, on patient care. With the implementation of decentralised pharmacy services, clinically trained pharmacists have established an enhanced responsibility for safe, rational drug therapy, and therapeutic drug monitoring, thus minimizing potential liability that may result from drug errors. In addition to the experience and high quality of the medical staff, it is useful to maintain a clinical pharmacy program on the ward.
N1099
The use of semi-elemental enteral feeds in children undergoing bone marrow transplantation
C. Elwig Imperial College Healthcare NHS Trust (London, UK)
Introduction: Medication toxicities can have a signifi cant impact on nutritional status. The catabolic effects of chemotherapy and Graft Versus Host Disease (GvHD), combined with limited oral intake necessitate an intensive approach to nutrition support. This study reviews the choice of enteral feeds with a particular focus on semi-elemental (SE) feeds for children undergoing transplantation for a variety of diagnoses. Choice of feed varies with age, diagnosis and prior treatment. Children with haemaglobinopathies have had no previous cytotoxic therapy and therefore present with a normally functioning gut. Mucositis a common side effect of conditioning which can affect the gut and in these cases a SE feed is indicated.
Methods:100 patients were transplanted from April 2001-November 2009. Indications included transfusion dependent B Thalassaemia (n = 55), HbSS (n = 12), Aplastic Anaemia (n = 8), Diamond Blackfan Anaemia (n = 5), Chronic Myeloid Leukaemia (n = 5), Fanconi Anaemia (n = 4), HLH (n = 4), Glanzmann Thrombasthaenia (n = 2), Acute Lymphoid Leukaemia (n = 1), Congenital Dyserythropoeitic Anaemia (n = 1), Acute Myeloid Leukaemia (n = 1), Acute Lymphoid Leukaemia (n = 1), JMML (n = 1). Age range 8 months-17 years (median age 6 years). Whole Protein (WP) feeds were used as standard starter regimens unless mucositis diagnosed. Nasogastric tubes (NGT) sited in 75 of 100 patients. 6 required parenteral nutrition. Of the 75 NG fed; 62 commenced WP feeds, 10 commenced SE feeds, 3 commenced elemental feeds. Of those 62 commenced on WP feeds, 28 changed to SE feeds. Results: 45% of children receving WP feeds were changed to a SE feed due to poor tolerance. Enteral Nutrition (EN) has a trophic effect on the gut, continuing NG feeding during maximal gut toxicity may accelerate healing. EN has been well documented to maintain mucosal integrity and reduce bacterial translocation. SE feeds are peptide based making them more absorbable in the event of gut atrophy caused by the side effects of conditioning. The decision to use WP feeds fi rst line needs further assessment. If 45% of our patients changed from WP to SE feeds for gut symptoms e.g. diarrhoea, then should we be considering the use of SE feeds as fi rst line to prevent gut complications. Could SE feeds prevent mucositis related diarrhoea? SE formulas are more expensive than WP feeds but cheaper and safer than PN. Ultimately all types of EN are effective in limiting nutritional insult after SCT and remains an accepted method for improving nutritonal status. Patients: One hundred and thirty nine patients from 0-18 years (mean 7.9) who were discharged after SCT. Seventy seven patients (55%) had received allo-transplants, and 62 patients (45%) underwent autologous SCT. Results: Forty six percent of patients were re-admitted. The interval from discharge to re-admission was 43 ± 60 days (range 1 -326). Causes for re-admission following allotransplant included fever (30%), gastro-intestinal complications (19%), and hemorrhagic cystitis (12%). Among auto-transplant patients, reasons for readmission included fever (41%), central line infection (18%), and gastro-intestinal complications (18%). Re-hospitalization was more frequent following allo (59%) vs. auto (29%) transplant (p < 0.005). Conclusion: Re-admission to hospital is frequent following discharge from the SCT unit. Educating parents and children regarding complications after SCT is very important in order to reduce anxiety, due to the high incidence of re-admission observed among these patients.
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Nurses Plenary Session 5: Challenges in HSCT nursing One of the most interesting and ever current professional concepts of morality is; respect for autonomy. In this paper I will be addressing autonomy specifi cally in the context of informed consent. Curiously, however, yet delicately interwoven with respect, it is necessary to separate autonomy from consent to understand its moral value in consent. As a clinical practitioner in Bone Marrow Transplant (BMT), I have encountered consent dilemmas wherein I feel that the autonomy issue has not been near fully addressed. With transplant complications, like neutropenic sepsis and graft versus host disease, end-of-life decisions may come into focus, due to intensive care management. This makes the patient population interesting and unique. Consent therefore to BMT should involve both consent to the procedure and to the life-threatening complications wherein there is a signifi cant element of risk. I am not suggesting that patients are currently not told about these complications, but I do feel that autonomy as a concept involved in patient choice is not suffi ciently developed. In this paper I wish to develop some dimensions of autonomy, teasing out what I feel may be useful and relevant in assisting the validity of consent. When I looked beyond the boundaries of consent to the procedure in clinical practice, this element of consent to risk might be referred to as; ultimate autonomy or fi nal life autonomous decision-making. This is an extension to immediate consent and it is what requires facilitation. This level of personal autonomy places responsibility, thus ownership on the patient who takes a decision regarding their life expectancy in the knowledge of the percentage risk. In clinical practice autonomy appears to have its limitations, wherein the responsibility of the autonomous decision-making beyond immediate consent may lie with the clinician, and not at all the individual. Whilst Mill might say; "over himself, over his body and mind, the individual is sovereign", I do believe that autonomy cannot or should not trump all other contributions form responsible agents, wherein paternalism may morally permissible. Thereby hangs the trouble with autonomy. Patients were monitored at home and in day-hospital from the infusion of PBSC to the end of aplasia. No difference was noted in the incidence of mucositis, grades or their duration. The incidence of febrile neutropenia and blood transfusions were lower in the outpatient group compared with inpatient group. We opted for a mixed strategy, combining a discharge the day of reinfusion of PBSC and a readmission at day 5 posttransplant. Patients and methods: From January 2007 to July 2009, 32 patients (pts) with MM received an autologous PBSC transplantation. Conditioning consisted of melphalan (200 mg/m²). All patients received growth factors from the fi fth day. They return home the day of transplant with advice on hygiene, taking temperature 2 times a day, an emergency phone service and without antibioprophylaxis. Results: The mean duration of aplasia was 6 days (d) with onset on day 6 after graft (range: 5-8 d) and a neutrophils recovery on day 12 (range: 10-15 d). No infectious complications were noted during the 5 days at home. At readmission, fever without microbiological documentation has been reported in 30 pts between day 6 to 12 after transplantation. Mucositis were observed on day 7 (range: 6-12 d) and lasted for 4 days in 8 pts. Digestive disorders (nausea, vomiting and diarrhea) occurred in 13 pts.Packed red cells and platelets transfusions were required by 8 and 31 patients, respectively.The day of discharge was in average the day 13 after graft (range: 10-15d). Conclusion: This procedure, well accepted by patients, showed no severe complications during output at home. An economy of 165 days of hospitalization was gained. Bone marrow transplantation activity is currently growing. Number of patients is increasing and the post-transplant followup requires more and more outpatient visits. Expansion of number of medical doctor (MD) is inadequate and care of every patient is diffi cult. We supposed that a specialized nurse, in particular for transplant's patients, could be able to survey at fi rst level our patients. So, MD activity could be concentrated only on patients dealing with complications. Nurse's follow-up should allow us: * A steadier planning of patients along the whole week, allowing nurses to spend more time with every patient. * To better anticipate complications as she (he) spends more time with patients (education, evaluation of compliance…). * To dedicate "doctor" time for the patients with complications (Graft versus Host disease (GVHD), infectious problem…). Previously, each patient was followed by a MD once a week for 3 months then the surveillance was gradually lightened. The position is proposed to nurses having 4 years' experience in hematology and particularly in transplanted patients. Initially, a one month period was planed during which all consultations were performed jointly with a MD. Currently, the nurse is evaluating each patient twice a week for early period and a joined medical evaluation is systematically planed every 15 days, altogether with the nurse. To assure this follow-up, she has to fi ll an assessment grid up. In diffi cult cases (for infectious disease, GVHD…), a visit with a MD is planed and the follow-up is resumed by the MD until patient condition stabilizes. Results: Since June 2009, 22 patients had been followed with this new organization. 185 outpatients clinics were performed by the nurse (mean duration 30 minutes). Only 25 (13%) consultations have urged a MD visit. All the phone calls are fi rst oriented to the nurse, who adequately regulates those requests according to clinical situation (management alone or orientation towards a doctor). The spared medical time is estimated 8 hours every week. The freed time allowed increasing the follow-up of the most fragile patients. These fi rst results showed no serious event for patients when comparing with precedent period. These preliminary results will be presented. Introduction: Patients undergoing allogeneic stem cell transplantation look forward to hospital discharge, but this moment is also associated with great fear. After a long time of hospitalization with high technical and medical support and intensive nurses' care the patients all of a sudden have to care for themselves again. To learn more about the arising issues and thereby to improve the patients' situation at home we have developed a questionnaire dealing with the most important problems in the fi rst seven weeks after discharge from hospital. Methods and results: From April 2009 up to August 2009, all patients were given a questionnaire at the time of discharge after allogeneic stem cell transplantation to be fi lled in anonymously. Amongst other items the questionnaire included questions concerning medication, precaution of hygiene and food, and social life. Twenty-nine of 35 patients (83%; females n = 13, males n = 16) actually answered. AML (45 %) was the most common diagnosis leading to allogeneic stem cell transplantation. The majority of the patients (55%) were in the age range of 41 to 60 years. In summary, 72% of the patients stated to be well-informed after discharge, but they described the following problems in more detail: social or social-legal issues (62%), hygienic measures with respect to their home (31%) and their own body (28%), management of nutrition/cooking at home (31%), and sexuality (38%). Conclusion: Since our analysis indicates that the patients have to be better prepared for discharge, we have developed a new concept. After hematologic recovery patients are now instructed to take care of the oral medication themselves. Nurses will not only instruct them but will also control the implementation and help them whenever there are diffi culties. Furthermore social workers will inform the patients of their rights and give them support in social-legal questions. The family has now to be included more closely in all of the patients' affairs. The aim of all these measures is to enable the patient to take care of himself and regain his independence and autonomy and give him more self-assurance. Background: With impressive improvements in survival rates, survivors of haematological malignancies constitute a large cohort of patients who are at risk of developing a range of late effects (LE) related to treatment. As the numbers of survivors grow it is increasingly important that they normalize their lives and incorporate healthy behaviours into their lifestyles in order to achieve optimal health outcomes. This paper describes the development of an innovative model of nurse-led care, delivered within the context of a multi-disciplinary, haematology, LE clinic. Objective: The LE Clinic at Peter MacCallum Cancer Centre was established in 2000. The need was identifi ed to implement nurse led initiatives that have the capacity to improve survivors' outcomes by recognizing and dealing with psychosocial distress, ensuring survivors have adequate information about their individual risks and by promoting sustained behavioral change.
Nurses
N1111
N1112
Method: Nurse-led consultations focus on key domains to explore prominent health related needs for cancer survivors. Information is presented to each individual in an education package, directed specifi cally at their concerns, problems or health risks. Since the incidence of emotional distress is signifi cant in cancer survivors, screening for emotional distress is undertaken. In addition, each survivor attending a nurse-led consultation receives an individualized survivorship care plan. This summarizes all elements of their past treatment, potential for LE, and recommendations for follow-up screening. The care plan focuses on health promotion, highlights the need for healthy behaviors and describes how to adopt these. Results: As of November 2009, 183 patients attend the Haematology LE clinic. The LE supportive care needs screening tool, education packages and survivorship care plans have become best practice within the clinic. Networks have been and continue to be established throughout Australia along with the development of LE clinics nationally. Conclusion: This innovative nurse-led model of survivorship follow-up is in its infancy. The interventions are delivered by an advanced practice haematology nurse, have been based on best available evidence and are endorsed by a multidisciplinary team of experts in the fi eld. As such, this initiative demonstrates an evolution in thinking about the development of nurse-led follow-up and may offer a useful model for the development of other nurse-led models of cancer survivorship care in the future. We present our experience of the use of the Flexiseal® faecal management device (FMD) in the care of patients with acute Graft vs. Host Disease (GVHD) of the bowel. Acute GVHD complicates allogeneic haemopoietic stem cell transplantation (HSCT) in 10-80%.The gut, along with skin and liver is targeted and lower gut involvement is characterised by profuse diarrhoea. Faecal incontinence (FI) increases perineal ulceration. In their study of 2,189 patients, Maklebust and Magnan (1994) found that FI was a stronger predictor of ulcer risk than other factors, including impaired mobility and malnutrition. The risk of ulceration was 22 x greater if FI was present. The FMD is a temporary containment system consisting of a soft fl exible, silicone catheter with a low-pressure balloon, fi lled with water to aid retention and attached to a collection bag. It is suitable for collection of stool and may be used < 28 days. The FMD is easy to insert and promotes a)patient comfort and dignity, b)reduced infection rates, c) release of nursing time and d) cost reduction (Binks, 2007 , Padmanabhan, 2007 . The application of the FMD post-HSCT has not previously been described. We report the use of the FMD in FI due to GVHD. All three of our patients had severe acute GVHD bowel (> 1500 mls of diarrhoea/day with abdominal pain and/or ileus). We initially observed the use of the FMD in the critical care setting in the management of GVHD post-liver transplant. In our own practice we then used an FMD in the palliative management of an unconscious patient with Glucksberg Grade 4 GVHD gut post allogeneic HSCT. Use of the device over the fi nal 5 days of life was uneventful. Following this experience we have gone on to use the FMD successfully in 2 further patients with severe acute GVHD gut post-HSCT both of whom are alive at Day + 222 and Day + 264 post-allograft. Observed direct benefi ts for the patients include promotion of dignity, facilitation of uninterrupted rest, absence
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